NEOTERP · Development of novel synthetic strategies for the synthesis of bioactive meroterpenoids
„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“
- Период
- 2018-09-01 → 2020-08-31
- Финансиране от ЕС
- 183 455 €
- Участници
- 1
- Схема
- MSCA-IF-EF-CAR
Линиите свързват координатора с партньорите.
Накратко на български
Меротерпеноидите и техните синтетични аналоги се създават чрез нови химични методи, включващи светлинни катализатори. Тези вещества се изучават, за да се открият нови лекарства срещу устойчиви видове рак и микробиални инфекции.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Development of novel synthetic strategies for the synthesis of bioactive meroterpenoids
The project concerns the development of innovative methodologies for the synthesis of novel bioactive natural products analogues. Thus, the aim of this project is to devise concise synthetic routes for the total synthesis of bioactive meroterpenoids natural products and their analogueues in order to fully explore their potential application for the discovery of new medicines to treat resistant cancers and resistant microbial infections. In particular, polyenes cyclisation via radical-cations intermediates initiated by photoredox catalysis or deriving from substrate that can readily form electrondeficient carbon centres is a highly promising way to induce such a kind of reactivity in substrates not containing strained cyclic “electron-sink” groups.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
The project concerns the development of innovative methodologies for the synthesis of novel bioactive natural products (meroterpenoids) and their potential application for the discovery of new medicines to treat resistant cancers and resistant microbial infections. The fundamentals of its originality and innovation are:a)The synthesis of a focused library of novel bioactive meroterpenoids, planned to have an impact in the fields of anticancer and anti-infective medicinal chemistry.b)The application of a flexible and concise dual biomimetic synthetic strategy, which will significantly impact the field of natural products synthesis focused on drug discovery.c)An extensive use of novel methods for polyene cyclisation including processes based on sulfite, sulfate, phosphate and other electrophilic initiators including radical cations generated by photoredox catalysis, coupled with polyketide aromatisation, will greatly impact in the field of cyclisation cascades in general as well as meroterpenoids synthesis.Dr Fabbrizzi is an experienced experimental scientist with substantial academic and industrial experience whose research career was interrupted in October 2015 due to funding crises in Italy. The award of a H2020 fellowship, if this proposal is successful, will be critical in supporting the resumption of his independent research career. Working in the supportive environment of Imperial College under the expert guidance of professor Barrett he will considerably reinforce his knowledge of natural product synthesis and drug discovery and will resume his position in the European research community improving his profile to face the current challenges of organic and medicinal chemistry. keywords/descriptors: Synthetic organic chemistry, Natural product synthesis, Medicinal chemistry
Оригинален текст от CORDIS (на английски).
Участници
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE · LondonКоординаторОбединеното кралство
Връзки
Данни: CORDIS, © Европейски съюз